Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors

NCT00507884 | Unknown

• 1 other identifier: 2004-0875
• Study Type: observational
• Target: 45
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical research study is to find out if "3 Tesla" MRI is as good as CT scan in the evaluation of kidney tumor(s). Objectives: To provide preliminary data to enable subsequent development of an MRI protocol at 3 Tesla for evaluation of renal tumors and their vascular supply, which can be adopted in patients who are unable to undergo CT evaluation.

Conditions

Kidney Neoplasms

Keywords

Kidney Neoplasms; Renal Tumors; Magnetic Resonance Imaging; 3 Tesla MRI; MRI

Outcome Measures

Primary Outcomes (1)

• Comparison of CT and MRI scans of patients with renal cell carcinoma in evaluating each of nine imaging variables.

  4 Years

Study Arms (1)

3 Tesla MRI

Patients with renal tumors scheduled to have a CT scan of the kidneys and abdomen.

Procedure: 3 Tesla MRI Scan

Interventions

3 Tesla MRI Scan PROCEDURE

MRI of the kidneys and abdomen to be done within 15 days following the routine CT and lasting 1 - 2 hours.

3 Tesla MRI

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Study participants with renal tumors scheduled to have a CT scan of the kidneys and abdomen.

You may qualify if:

• Patients who have undergone or are due to undergo a CT Renal Protocol study, in the course of pre-operative evaluation for renal tumor surgery.
• Written informed consent will be obtained.

You may not qualify if:

• Patients with an allergy to both gadopentetate dimeglumine and gadodiamide MRI contrast agents.
• Patients with certain metallic implants, e.g., cardiac pacemakers, cardiac defibrillators, aneurysm clips, neurostimulators, and certain metallic foreign bodies. Implanted medical devices must be MRI compatible at 3.0 Tesla field strengths.
• Patients with claustrophobia, or requiring sedation for the MRI scan.

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

• University of Texas MD Anderson Cancer Center Website

MeSH Terms

Conditions

Kidney Neoplasms; Carcinoma, Renal Cell

Condition Hierarchy (Ancestors)

Urologic Neoplasms; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Kidney Diseases; Urologic Diseases; Male Urogenital Diseases; Adenocarcinoma; Carcinoma; Neoplasms, Glandular and Epithelial; Neoplasms by Histologic Type

Study Officials

• Chaan Ng, MD

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 26, 2007
• First Posted: July 27, 2007
• Study Start: March 1, 2005
• Primary Completion: September 1, 2022
• Study Completion: September 1, 2022
• Last Updated: December 31, 2020

Record last verified: 2020-12

Locations

US (1)